N1,N1-diethyl-N2-(4-methylbenzo[d]thiazol-2-yl)ethane-1,2-diamine hydrochloride

Catalog No. :
ACMICB023
CAS No. :
1421500-32-4
Molecular Formula :
C14H22ClN3S
Molecular Weight :
299.87

IUPAC Name:N1,N1-diethyl-N2-(4-methylbenzo[d]thiazol-2-yl)ethane-1,2-diamine hydrochloride

N1,N1-diethyl-N2-(4-methylbenzo[d]thiazol-2-yl)ethane-1,2-diamine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$576.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN1,N1-diethyl-N2-(4-methylbenzo[d]thiazol-2-yl)ethane-1,2-diamine hydrochloride
IUPAC NameN1,N1-diethyl-N2-(4-methylbenzo[d]thiazol-2-yl)ethane-1,2-diamine hydrochloride
Molecular FormulaC14H22ClN3S
Molecular Weight299.87
SMILESCC1=C2N=C(NCCN(CC)CC)SC2=CC=C1.[H]Cl
InChI KeyQXGQCLZFWWSWHW-UHFFFAOYSA-N
SynonymN1,N1-Diethyl-N2-(4-methylbenzo[d]thiazol-2-yl)ethane-1,2-diamine hydrochloride
CAS No.1421500-32-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACMICB023 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBRNS174 route compound structure diagram
    ACBRNS17452198-62-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMICB023 route product structure diagram
    ACMICB0231421500-32-4
Inquiry

2. ACMICB023 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBRNS174 route compound structure diagram
    ACBRNS17452198-62-6 In Stock
  2. Plus
  3. ACXKNC160 route compound structure diagram
    ACXKNC16073443-76-2 In Stock
  4. Then
  5. ACMICB023 route product structure diagram
    ACMICB0231421500-32-4
Inquiry

Comments (0)